Nanobiotix S.A. (NBTX) stock
NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
$26.90−0.55 (-2.00%)
Close on Nov 18, 2026Market cap $1.30BP/E –Yield –
Nanobiotix operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -€33.42M. The highest annual figure on record is -€12.48M in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -€33.42M | – |
| FY2024 | Dec 31, 2024 | -€19.55M | – |
| FY2023 | Dec 31, 2023 | -€12.48M | – |
| FY2022 | Dec 31, 2022 | -€37.10M | – |
| FY2021 | Dec 31, 2021 | -€29.87M | – |
| FY2020 | Dec 31, 2020 | -€27.54M | – |
| FY2019 | Dec 31, 2019 | -€41.17M | – |
| FY2018 | Dec 31, 2018 | -€25.99M | – |
See a number that looks wrong?